EDGAR Filing Documents for 0001193125-17-169703

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001193125-17-169703

Filing Date

2017-05-15

Accepted

2017-05-15 08:01:05

Documents

Period of Report

2017-05-15

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	d350841d6k.htm	6-K	11947
2	EX-99.1	d350841dex991.htm	EX-99.1	258597
3	EX-99.2	d350841dex992.htm	EX-99.2	218428
4	EX-99.3	d350841dex993.htm	EX-99.3	10009
5	EX-99.4	d350841dex994.htm	EX-99.4	10012
6	GRAPHIC	g350841g96f46.jpg	GRAPHIC	2962
7	GRAPHIC	g350841newimg01.jpg	GRAPHIC	126522
8	GRAPHIC	g350841nnewimg02.jpg	GRAPHIC	128717
	Complete submission text file	0001193125-17-169703.txt		865969

Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8

Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272

Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)